Rivus Pharmaceuticals Inc., a drug developer focused on obesity treatments, is considering a US initial public offering as ...

Big Four firm EY puts the investment needs of all German electricity grids at €281bn by 2030. A plan to sell the unit to the ...

Dave Duffield hopes to complete an IPO hat trick with Ridgeline, which aims to replicate his success in HR software for the ...

Flutterwave CEO GB discusses the company's recent administrative changes, product focus, and their implications for the ...

CAMP4 Therapeutics, a biopharmaceutical company backed by healthcare giant Kaiser Permanente, said on Monday it was targeting ...

Septerna, Inc. aims to raise $100 million in an IPO to advance its clinical-stage biopharma treatments for endocrine diseases ...

Chery Holdings Co. is considering a Hong Kong initial public offering for its automotive unit that could value it at about 50 ...

RNA biotech CAMP4 Therapeutics has marked out plans for a $67 million IPO, with inflammation-focused Upstream Bio pegging its ...

Hydrocarbon-based chemicals supplier Shiv Texchem has mopped up Rs 28.87 crore from 10 anchor investors on October 7, a day ...

Garuda Construction and Engineering IPO opens for subscription on October 8, offering shares at ...

The company has finalised allocation of 78,95,138 equity shares to seven anchor investors at a price of Rs 95 per share.

Garuda Construction and Engineering has secured Rs 75 crore from anchor investors ahead of its IPO, which opens for ...